Skip to content

Effectiveness of nano carbonate apatite toothpaste on root dentine hypersensitivity in periodontitis patients: a randomized controlled trial

Effectiveness of nano carbonate apatite toothpaste on root dentine hypersensitivity in periodontitis patients: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17011678
Enrollment
Unknown
Registered
2017-06-16
Start date
2017-07-01
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontitis

Interventions

control:nano carbonate apatite free toothpaste
test group:nano carbonate apatite toothpaste

Sponsors

The Second Affiliated Hospital of Zhejiang University School of Medcine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. aged 18 to 70 years; 2. no systemic disease; 3. with a diagnosis of moderate to severe periodontitis who need to be treated with non-surgical periodontal treatment (scaling and root planing) in one session; 4. satisfactory dental restorations and no caries in all of the teeth; 5. pre-existing dentine hypersensitivity in at least two teeth(VAS between 3.0 to 8.0)and can be diagnosed by visual or probing inspection; 6. not using agents to treat hypersensitivity in the past 6 months

Exclusion criteria

Exclusion criteria: 1. smoking; 2. subjects with gross oral pathology, chronic disease, extremely advanced periodontal disease, periodontal treatment within the last 12 months; 3. hypersensitive teeth with mobility greater than one; 4. teeth with extensive (implicating equal or more than 2/3 of the crown) and/or defective restorations, suspected pulpitis, caries or cracked enamel; 5. subjects with removable appliances, such as removable partial dentures or orthodontic retainers; 6. subjects taking anticonvulsants, antihistamines, antidepressants, sedatives, tranquilizers, anti-inflammatory drugs or daily analgesics within 1 month prior to enrollment to the study or if they started taking them during the course of the study; 7. pregnant or lactating women; 8. subjects who are participating in any other clinical study or who have participated in a desensitizing toothpaste study or who used a desensitizing toothpaste within the last 3 months, or had a dental prophylaxis within 2-weeks prior to the projected date of the screening visit; 9. subjects with a history of allergy to the test products, or allergies to oral care/personal care consumer products or their ingredients.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;

Secondary

MeasureTime frame
Schiff Cold Air Sensitivity;

Countries

China

Contacts

Public ContactDing Peihui

The Second Affiliated Hospital of Zhejiang University School of Medcine

phding@163.com+86 18957108518

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026